$ATGE if you want to be a nurse or go into health services, this company has a monopoly on the necessary education/licensing. combine with the upward trend in necessary elder care from boomers/gen x along with job displacement over the next 3-4 years due to AI and you have a recipe for massive gains.
$ATGE just reshaped its healthcare strategy — and Covista is the result. 👀
Covista is emerging from ATGE’s healthcare-focused overhaul, positioning itself as workforce infrastructure designed to ease America’s medical staffing shortage. A clear pivot with a clear mission.
See how this transformation is shaping the new healthcare play 👉 https://www.zacks.com/stock/news/2836243/adtalem-rebrands-as-covista-with-focus-on-healthcare-workforce-needs?cid=sm-stocktwits-2-2836243-teaser-32297&ADID=SYND_STOCKTWITS_TWEET_2_2836243_TEASER_32297
Adtalem Global Education transforms into Covista — what it means for investors! 🚀
$ATGE will become Covista, aligning its operations with the rising demand for healthcare professionals. The move underscores Covista’s commitment to addressing the U.S. healthcare workforce crisis by expanding training capacities and supporting underserved students.
Discover what this strategic shift means for the stock 👉 https://www.zacks.com/stock/news/2836243/adtalem-rebrands-as-covista-with-focus-on-healthcare-workforce-needs?cid=sm-stocktwits-2-2836243-body-32283&ADID=SYND_STOCKTWITS_TWEET_2_2836243_BODY_32283
$ATGE Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $2.14 up 5.42% YoY
• Reported revenue of $503.38M up 12.43% YoY
• Adtalem expects fiscal year 2026 capital expenditures to include IT investments and new campus development, alongside approximately $4.5 million in new operating lease liabilities commencing in Q3 FY26.
$ATGE Earnings - Q2/2026
Revenue: $503.38M ✅ vs. $490.76M est.
EPS: $2.43 ✅ vs. $2.27 est.
Adtalem Global Education posts Q2 FY2026 results, marking the tenth straight quarter of enrollment growth with 97,000 students, up 6.3% year over year. The company raises FY2026 adjusted EPS guidance and maintains revenue guidance; Investor Day is set for Feb. 24, 2026. CEO Steve Beard says the firm is addressing healthcare workforce gaps at scale, embedding AI within programs, and returned $165 million of capital to shareholders.
